Not a lock but a very strong possibility.
There has been a lot of DD and I agree with you... EVERYONE should make an educated decision and not rely on the opinions of anyone on this board or anywhere else, imo.
Opinions are just that and everyone has one. People even interpret facts differently but they are the only thing we can truly rely on.
So here are some very important facts to consider.
$ Nuvilex has proprietary rights to Cell-in-a-Box(R) technology which has already successfully completed Phase I/II trials in Europe. (Check website for results which were better than the current gold standard provided by Celgene.)
$ They have made significant progress toward next Phase commencement and have reason to believe they may qualify for Accelerated Approval status. (See recent news.)
$ Two of the most accredited world-renowned pancreatic oncologists, Doctors Von Hoff and Lohr are quoted as being excited about leading the upcoming trials to be conducted in the U.S. and abroad for marketing in both areas. (See recent news)
$ Dr Lohr said, that he was very happy to see "our original concept brought back to life". (See yesterday's news)
Not a lock, as is nothing in life.... But, OH! The VERY STONG possibilities are crystal clear to me.
And as long as you are investing only what you can afford, personally still waiting on funds to strenghten my position, there is really nothing scary at all in believing the facts regarding this technology.
There is one person's opinion I highly value in this arena and his words of wisdom are...
$$$ "The stock market remains an exceptionally efficient mechanism for the transfer of wealth from the impatient to the patient."
--Warren Buffet
GLTU, GLTA
NVLX - Cell-in-a-Box(R)
News 
Market Data 
Discover 
AI
